Bio Europe Content hub
Turn Data Into Direction at BIO 2026
Nov 9–11, 2026 | Cologne, Germany | Booth 8-56
Get the independent data, forecasting and competitive context you need to walk into every meeting with confidence.
Event Highlights
Panel Discussion
Unlocking Pharma’s Productivity Potential
Monday, 9 November 2026 11:00 - 11:45 AM
Powered by leading analyst intelligence and data-driven insights, this session offers a comprehensive exploration of the evolving therapeutic landscape. Dive into emerging trends, market dynamics, and investment opportunities across key therapeutic areas, and uncover how shifting R&D pipelines, regulatory changes, scientific breakthroughs, and technological advancements are transforming the biopharma industry. Gain a forward-looking perspective on the most promising therapeutic areas and high-growth investment opportunities, equipping you with the strategic insights needed to navigate 2026 and beyond.
Moderator
Daniel Chancellor
VP, Thought Leadership, Norstella
Read Bio
Daniel has more than 15 years of experience in the biopharma industry, spanning roles in drug discovery, market analysis, competitive intelligence, and strategic consulting.
Beginning his advisory career at Citeline, Daniel now oversees the thought leadership program for Norstella and its constituent companies, producing unique research that guides clients through ever-changing industry dynamics. As part of this, Daniel regularly participates in webinars, conferences, and other speaking arrangements, and he has provided expert insights across a wide range of leading industry and business publications.
Prior to joining Citeline, Daniel worked as a medicinal chemist at Summit Therapeutics and graduated with First Class Honors in Natural Sciences from the University of Bath.
Speakers
Hakan Goker
Managing Director at M Ventures
Geraldine Ng
VP Rare Disease & Cell Therapy Business Development, Corporate Development at Novo Nordisk
Kiran Reddy
Senior Managing Director at Blackstone Life Sciences
Steffen Thirstrup
CMO at European Medicines Agency
Meet our team attending Bio-Europe
Jim Chuck
SVP, Sales EMEA & APAC
Trajko Spasenovski
VP, Custom Solutions
Vincent Spurr
Director, GTM Solutions Consulting
Sarah D'Intino
Senior Strategic Customer Success Manager
Tyrrell Okolo
Strategic Account Manager, Senior Director
Andrew Davis
New Business Development, Senior Director
Matt McGimpsey
Global Account Director
Sam Fuller
Account Manager, SME Pharma Accounts
Antoine Verslype
Business Development Director
A competitive intelligence agent built for pharma, powered by Evaluate’s parent company Norstella.
AGENTIC AI FOR BIOPHARMA
Three decades of clinical, commercial, and market access data. Linked, curated, and ready to work. Ask a question in plain language and get a sourced, decision-ready output — landscapes, drug profiles, catalyst timelines — in minutes.
No model trained on public data can replicate this data network.
"There are two kinds of AI in this industry right now. One is built for demos. The other is built for decisions."
Use Cases
How Evaluate Helps
Our experts will help you identify the tools and insights that support your strategic, commercial, or investment priorities.
Asset Screening
Benchmark Internal Forecasts with Consensus Forecasts
Screen and validate potential in‑licensing or acquisition assets by comparing internal views with trusted consensus forecasts to spot positive signals and red flags.
Focus on Specific Business Questions
Use the NPV Analyzer to project sales, peak revenue, and costs, identifying risks and opportunities to generate actionable recommendations.
Build and Inform Your Investment Strategy
Analyze markets, macrotrends, and companies to identify funding or acquisition targets early, assessing R&D risk and return from a single integrated view.
Company Profiling
Find Opportunities That Align With Your Strategy
Identify companies that match your objectives by evaluating their financials, strategic direction, and key upcoming milestones.
Track And Manage Your Targets
Build and manage target lists while assessing partnership openness and comparing phase‑level assets against competitors.
Defend And Validate Your Assumptions
Use robust tools and audited data to identify opportunities, reduce portfolio risk, and refine company profiles to maximize ROI.
Deal Benchmarking
Leverage Accurate Forecasts
Use transparent analyst‑driven forecasts and historical comparables to guide strategy, identify acquisition opportunities, and structure smarter deals.
Create Custom Benchmarks And Validate Internal Valuations
Benchmark competitor deal terms, including upfronts, milestones, and royalties—to validate internal valuations and understand true asset value.
Optimize Existing Workflows
Compare key metrics, validate assumptions, and streamline decisions using tailored intelligence powered by intuitive search and filtering.
Have a bespoke requirement?
Every strategic challenge is different. If you need to answer a unique commercial question or require tailored support beyond standard solutions, our consulting team will work with you to design an approach that fits your objectives, timelines, and data needs.
Ready to see how Evaluate can help you make smarter decisions?
Get in touch with our team to explore the right solutions for your business.
Resources
Read our latest use‑cases and content that help BD teams strengthen strategy, validate opportunities, and shape decisions that truly matter.
